Germany / Highest Honours for BioNTech Founders; Bayer’s Growth Predictions; Merck Making Further French Investments
A roundup of some of the most important recent news from German pharma, including state honours for the founders of…
Top Stories
Turkey / The Impact Of Brexit On CE Certificates Issued By UK Notified Bodies
The shockwaves from the UK's exit from the European Union have resounded across the continent, including in Turkey, where the country's pharmaceutical and medical devices regulator has had to adjust…
The Long Read / Switzerland: Staying the Course
This article forms part of Healthcare & Life Sciences Review: Switzerland February 2021, a comprehensive…
China / Boehringer Ingelheim's Stroke Rehab Centre Success & Continuing China Push
In March 2018, German pharma player Boehringer Ingelheim (BI)‘s Consanas Rehabilitation and the Shanghai…
LatAm / COVAX Rollout in Colombia; União Quimica to Manufacture Sputnik Vaccine in Brazil; Mexico Cannabis Update
The latest LatAm pharma news, including COVID-19 vaccine rollouts in Colombia, Brazil, and Mexico as well as legal…
Turkey / Top Biopharma Investors 2020
As Turkey’s pharmaceutical industry makes its first steps away from competitive low-value generics towards…
Europe / Can The Beating Cancer Plan Make it an Innovation Leader?
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
In Conversation
Laurent Massuyeau – CEO, iQone Healthcare, Switzerland
Laurent Massuyeau introduces Swiss biosimilar commercialisation specialist iQone healthcare, why it made sense to base the company in Switzerland, its partnership deal with Korean biosimilar giant Celltrion, and where iQone’s future lies. For me, Switzerland is one of the best places in Europe to start a business Having previously worked in both animal health and Big Pharma, what was…
Latest Reports
Focus on China
Public Insurance Coverage for Rare Disease Patients in…
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare…
New Drug Approvals in China 2020
The Chinese NMPA’s drug approval list for 2020 includes a surge in approvals…
Top 10 Chinese Pharma Companies 2020
The Top 10 Chinese pharma companies for 2020 ranked by overall revenues. Taken…
Boehringer Ingelheim’s Stroke Rehab Centre Success…
In March 2018, German pharma player Boehringer Ingelheim (BI)'s Consanas…
Read more: China >>
Focus on Vaccines
Italy: Stevanato’s $5 bn valuation; Zolgensma Approval;…
The latest from Italian pharma, including the foreign minister’s plea for…
LatAm Pharma News: COVAX Rollout in Colombia; União Quimica…
The latest LatAm pharma news, including COVID-19 vaccine rollouts in Colombia,…
The COVID-19 Vaccine Rush: Nationalism, Access & IP…
The global rush to secure access to COVID-19 vaccines has led to accusations…
Mexico: US Vaccine Tourism; CanSino Stepping Up; AMLO Calls…
The latest from Mexico’s fight against COVID-19, including news of vaccine…
Read more: Vaccines >>
Focus on Singapore
Southeast Asia: Singapore Pharma Production Surge;…
The latest from Southeast Asian pharma, including soaring output in Singapore,…
HSA: APAC’s Regulatory Gold Standard
As the most important pharma hub in its region, and one of the most important…
Medtech’s Post-COVID Paradigm in APAC
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech…
Singapore Pharma Industry Snapshot 2020
Singapore is home to a wide range of biopharmaceutical company headquarters,…
Read more: Singapore >>
Focus on Europe
After Brexit: Focus on the New Pharmaceutical Strategy for…
Writing in the February edition of DIA’s Global Forum magazine, Thomas Kühler…
Europe: EMA Medicine Approvals 2020
The full list of medicines recommended for approval by the European Medicines…
Latvia: Striving to Catch Up to its Neighbours on Innovation…
Dr Valters Bolevics, director general of the Association of International…
Read more: Europe >>
Focus on USA
Securing the Conditions to Secure Our Meds
The AAM’s Dan Leonard highlights the savings impact that generic and…
Novavax: From No-Hoper to COVID-19 Vaccine Saviour?
From almost being de-listed by the NASDAQ stock index in 2018 due to poor…
NORD Chief Strategy Officer on Health Equity’s Vital…
With Rare Disease Day coming up on February 28th, one of the leading…
5 US Rare Disease Start-Ups to Watch
Following on from our profile on five of the most promising clinical-stage…
Read more: USA >>
Focus on Switzerland
Swissmedic New Drug Approvals 2020
Regarded as one of the world’s leading regulatory bodies, Swissmedic stands…
Ichnos CEO on Glenmark Legacy, Biotech Transformation &…
After an illustrious career in oncology R&D, contributing greatly to the…
Building a Health Data Ecosystem in Switzerland
Although Switzerland is ahead of many of its competitors in Europe on levels of…
Biogen’s Swiss Head on Benefits of Diverse Experience…
A trained physician with several years of practice under her belt, Katharina…
Read more: Switzerland >>
Focus on MEA
MEA: Pfizer’s Saudi Transformation; Urgent Call for Arab…
The latest news from Middle East & North African pharma, including…
Saudi Arabia: SFDA CEO Sets Out Strategic Priorities
In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey,…
5 Saudi Arabian Pharma Companies to Know
Following on from our list of the overall top 10 companies in the Saudi Arabian…
5 Things to Know about Saudi Arabian Pharma
A rundown of five things to know about the USD 8.2 billion Saudi pharma market,…